Literature DB >> 19216093

Finnish multicenter study on the midterm results of use of the Zenith stent-graft in the treatment of an abdominal aortic aneurysm.

Terhi Nevala1, Fausto Biancari, Hannu Manninen, Pekka-Sakari Aho, Pekka Matsi, Kimmo Mäkinen, Wolf-Dieter Roth, Kari Ylönen, Mauri Lepäntalo, Jukka Perälä.   

Abstract

PURPOSE: To assess the midterm results of endovascular repair of abdominal aneurysm (AAA) with a Zenith stent-graft.
MATERIALS AND METHODS: Between January 2001 and December 2005, a Zenith stent-graft was employed for endovascular repair of an infrarenal AAA in 206 patients. The mean patient age (+/-standard deviation) was 73.2 years +/- 7.3. Bifurcated grafts were used in 196 patients (96.1%), aortouni-iliac grafts were used in seven patients (3.4%), and a tubular graft was used in one patient (0.5%). The mean follow-up period was 2.4 years +/- 1.7.
RESULTS: The 30-day mortality rate was 2.9%. The overall survival rates at 1-, 3-, and 5-year follow-up were 93.3%, 78.7%, and 64.5%, respectively. None of the patients died of AAA rupture. The primary and assisted technical success rates 1 week after endovascular aneurysm repair were 82.0% and 90.3%. The primary clinical success rates at the 1-, 3-, and 5-year follow-up were 90.6%, 85.6%, and 83.5%. Twenty-seven patients (13.1%) underwent a secondary intervention during the study period.
CONCLUSIONS: An 83% rate of freedom from repeat vascular intervention over a period of 5 years as well as an absence of structural failures or aneurysm ruptures demonstrates that a Zenith stent-graft is associated with good midterm results.

Entities:  

Mesh:

Year:  2009        PMID: 19216093     DOI: 10.1016/j.jvir.2008.12.410

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  3 in total

1.  Elective endovascular aortic repair conversion for type Ia endoleak is not associated with increased morbidity or mortality compared with primary juxtarenal aneurysm repair.

Authors:  Salvatore T Scali; Michael M McNally; Robert J Feezor; Catherine K Chang; Alyson L Waterman; Scott A Berceli; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2014-03-27       Impact factor: 4.268

2.  Three-Year Results of the Endurant Stent Graft System Post Approval Study.

Authors:  Sarah E Deery; Katie E Shean; Alexander B Pothof; Thomas F X O'Donnell; Barbara A Dalebout; Jeremy D Darling; Thomas C F Bodewes; Marc L Schermerhorn
Journal:  Ann Vasc Surg       Date:  2018-03-02       Impact factor: 1.466

3.  Type III Endoleak of a Disconnected Stent-graft Limb.

Authors:  Yusuke Ochiumi; Yoriyasu Suzuki; Yasuhiro Oba
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.